Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

(1992): Ramselaar CG+, Br J Urol 70, 451 (1985): Cheung J+, Anaesth Intensive Care 13, 429 (1982): Staab W+, Stomatol DDR (German) 32, 700 Dermatitis (2007): Kaminska R+, Contact Dermatitis 56(6), 358 (contact) (2001): Barnett L+, Ostomy Wound Manage 47(9), 47 (2001): Barrazza V, Contact Dermatitis 45(1), 42 (1998): Ebo DG+, J Allergy Clin Immunol 101, 128 (1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 18, 3295 (1995): Stingeni L+, Contact Dermatitis 33, 172 (1990): Reynolds NJ+, Contact Dermatitis 22, 103 (1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84 (1987): Osmundsen PE+, Ugeskr Laeger (Danish) 149, 3048 (1985): Lasthein Andersen B+, Contact Dermatitis 13, 307 (5.4%) (1983): Shoji A, Contact Dermatitis 9, 156 (1982): Osmundsen PE, Contact Dermatitis 8, 81 (1981): Roberts DL+, Contact Dermatitis 7, 326 Facial edema (10%) Vaginal pruritus (2004): Wilson CM+, J Acquir Immune Defic Syndr 35(2), 138 Other Anaphylactoid reactions/Anaphylaxis (2004): Beaudouin E+, Allerg Immunol (Paris) 36(4), 123 (2004): Krautheim AB+, Contact Dermatitis 50(3), 113 (2001): Garvey LH+, Acta Anaesthesiol Scand 45(10), 1204 (4 cases) (2001): Knight BA+, Intern Med J 31(7), 436 (2001): Lockhart AS+, Br J Anaesth 87(6), 940 (2001): Stephens R+, Br J Anaesth 87(2), 306 (with sulfadiazine) (2000): Pham NH+, Clin Exp Allergy 30, 1001 (1999): Autegarden JE+, Contact Dermatitis 40, 215 (1999): Snellman E+, JAmAcadDermatol40, 771 (1998): Ebo DG+, J Allergy Clin Immunol 101, 128 (1998): Nikaido S+, Masui (Japanese) 47, 330 (1998): Olivieri J+, Schweiz Med Wochenschr 128, 1508 (1998): Terazawa E+, Anesthesiology 89, 1296 (1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 118, 3295 (1997): Chisholm DG+, BMJ 315, 785 (1997): Fujita S+, Masui (Japanese) 46, 1118 (2 cases) (1996): Torricelli R, Clin Exp Allergy 26, 112 (1995): Parker F+, Anaesth Intensive Care 23, 126 (1994): de Groot AC+, Ned Tijdschr Geneeskd (Dutch) 138, 1342 (1994): Okuda T+, Masui (Japanese) 43, 1352 (1994): Russ BR+, Anaesth Intensive Care 22, 611 (1994): Visser LE+, Ned Tijdschr Geneeskd (Dutch) 138, 778 (1992): Evans RJ, BMJ 304, 686 (1992): Harukuni I+, Masui (Japanese) 41, 455 (1992): Peutrell JM, Anaesthesia 47, 1013 (1990): Wong WK+, Contact Dermatitis 22, 52 Hypersensitivity (2001): Lauerma AL, Contact Dermatitis 44(1), 59 (1998): Burlington B, Ostomy Wound Manage 44, 84 (1994): Aalto-Korte K+, Duodecim (Finnish) 110, 2013 (1989): Okano M+, Arch Dermatol 125, 50 (6 cases) (1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84 (1986): Ohtoshi T+, Clin Allergy 16, 155 (1986): Yaacob H+, JOralMed41, 145 CHLORMEZANONE Trade name: Trancopal Indications: Anxiety Category: Anxiolytic; Central muscle relaxant Half-life: 24 hours Reactions CHLORMEZANONE 117 Skin Edema Erythema multiforme Exanthems (1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223 Fixed eruption (1998): Leal G, Fortaleza, Brazil (from Internet) (observation) (1998): Lee AY, Contact Dermatitis 38(5), 258 (1998): Mahboob A+, Int J Dermatol 37, 833 (1995): Rademacher D+, Contact Dermatitis 32, 117 (1992): el-Sayed F+, Ann Dermatol Venereol (French) 119, 671 (1991): Lee AY+, Drug Intell Clin Pharm 25, 604 (1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223 (1988): McFadden N, Dermatologica 176, 106 (1985): Kauppinen K+, Br J Dermatol 112, 575 (1985): Verbov J, Dermatologica 171, 60 (with acetaminophen) (1983): Mohamed KN+, Int J Dermatol 22, 548 Peripheral edema Pruritus Rash (sic) (1991): Lee AY+, Drug Intell Clin Pharm 25, 604 (passim) Stevens–Johnson syndrome (1995): Roujeau JC+, NEnglJMed333(24), 1600 (1995): Wolkenstein P+, Drug Saf 13, 56 Toxic epidermal necrolysis (1998): von Boxberg C+, Dtsch Med Wochenschr (German) 123, 866 (fatal) (1996): Blum L+, JAmAcadDermatol34, 1088 (1995): Roujeau JC+, NEnglJMed333(24), 1600 (1993): Correia O+, Dermatology 186, 32 (1992): Saiag P+, JAmAcadDermatol26, 567 (1991): Rosenthal E+, Presse Med (French) 20, 1459 (1987): Guillaume JC+, Arch Dermatol 123, 1166 (1983): Tagami H+, Arch Dermatol 119, 910 Urticaria Mucosal Xerostomia

118 CHLORMEZANONE Other Death CHLOROQUINE Trade names: Aralen (Sanofi-Aventis); Avloclor; Chlorquin; Emquin; Heliopar; Lagaquin; Malarivon Indications: Malaria, rheumatoid arthritis, lupus erythematosus Category: Antimalarial; Antiprotozoal; Disease-modifying antirheumatic Half-life: 3–5 days Clinically important, potentially hazardous interactions with: acitretin, antacids, cholestyramine, dapsone, furazolidone, hydroxychloroquine, methotrexate, methoxsalen, penicillamine, sulfonamides Reactions Skin Acute generalized exanthematous pustulosis (AGEP) (1998): Janier M+, Dermatology 196, 271 Angioedema (

(1992): Ramselaar CG+, Br J Urol 70, 451<br />

(1985): Cheung J+, Anaesth Intensive Care 13, 429<br />

(1982): Staab W+, Stomatol DDR (German) 32, 700<br />

Dermatitis<br />

(2007): Kaminska R+, Contact Dermatitis 56(6), 358 (contact)<br />

(2001): Barnett L+, Ostomy Wound Manage 47(9), 47<br />

(2001): Barrazza V, Contact Dermatitis 45(1), 42<br />

(1998): Ebo DG+, J Allergy Clin Immunol 101, 128<br />

(1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 18, 3295<br />

(1995): Stingeni L+, Contact Dermatitis 33, 172<br />

(1990): Reynolds NJ+, Contact Dermatitis 22, 103<br />

(1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84<br />

(1987): Osmundsen PE+, Ugeskr Laeger (Danish) 149, 3048<br />

(1985): Lasthein Andersen B+, Contact Dermatitis 13, 307<br />

(5.4%)<br />

(1983): Shoji A, Contact Dermatitis 9, 156<br />

(1982): Osmundsen PE, Contact Dermatitis 8, 81<br />

(1981): Roberts DL+, Contact Dermatitis 7, 326<br />

Facial edema (10%)<br />

Vaginal pruritus<br />

(2004): Wilson CM+, J Acquir Immune Defic Syndr 35(2), 138<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis<br />

(2004): Beaudouin E+, Allerg Immunol (Paris) 36(4), 123<br />

(2004): Krautheim AB+, Contact Dermatitis 50(3), 113<br />

(2001): Garvey LH+, Acta Anaesthesiol Sc<strong>and</strong> 45(10), 1204 (4<br />

cases)<br />

(2001): Knight BA+, Intern Med J 31(7), 436<br />

(2001): Lockhart AS+, Br J Anaesth 87(6), 940<br />

(2001): Stephens R+, Br J Anaesth 87(2), 306 (with sulfadiazine)<br />

(2000): Pham NH+, Clin Exp Allergy 30, 1001<br />

(1999): Autegarden JE+, Contact Dermatitis 40, 215<br />

(1999): Snellman E+, JAmAcadDermatol40, 771<br />

(1998): Ebo DG+, J Allergy Clin Immunol 101, 128<br />

(1998): Nikaido S+, Masui (Japanese) 47, 330<br />

(1998): Olivieri J+, Schweiz Med Wochenschr 128, 1508<br />

(1998): Terazawa E+, Anesthesiology 89, 1296<br />

(1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 118, 3295<br />

(1997): Chisholm DG+, BMJ 315, 785<br />

(1997): Fujita S+, Masui (Japanese) 46, 1118 (2 cases)<br />

(1996): Torricelli R, Clin Exp Allergy 26, 112<br />

(1995): Parker F+, Anaesth Intensive Care 23, 126<br />

(1994): de Groot AC+, Ned Tijdschr Geneeskd (Dutch)<br />

138, 1342<br />

(1994): Okuda T+, Masui (Japanese) 43, 1352<br />

(1994): Russ BR+, Anaesth Intensive Care 22, 611<br />

(1994): Visser LE+, Ned Tijdschr Geneeskd (Dutch) 138, 778<br />

(1992): Evans RJ, BMJ 304, 686<br />

(1992): Harukuni I+, Masui (Japanese) 41, 455<br />

(1992): Peutrell JM, Anaesthesia 47, 1013<br />

(1990): Wong WK+, Contact Dermatitis 22, 52<br />

Hypersensitivity<br />

(2001): Lauerma AL, Contact Dermatitis 44(1), 59<br />

(1998): Burlington B, Ostomy Wound Manage 44, 84<br />

(1994): Aalto-Korte K+, Duodecim (Finnish) 110, 2013<br />

(1989): Okano M+, Arch Dermatol 125, 50 (6 cases)<br />

(1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84<br />

(1986): Ohtoshi T+, Clin Allergy 16, 155<br />

(1986): Yaacob H+, JOralMed41, 145<br />

CHLORMEZANONE<br />

Trade name: Trancopal<br />

Indications: Anxiety<br />

Category: Anxiolytic; Central muscle relaxant<br />

Half-life: 24 hours<br />

Reactions<br />

CHLORMEZANONE 117<br />

Skin<br />

Edema<br />

Erythema multiforme<br />

Exanthems<br />

(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223<br />

Fixed eruption<br />

(1998): Leal G, Fortaleza, Brazil (from Internet) (observation)<br />

(1998): Lee AY, Contact Dermatitis 38(5), 258<br />

(1998): Mahboob A+, Int J Dermatol 37, 833<br />

(1995): Rademacher D+, Contact Dermatitis 32, 117<br />

(1992): el-Sayed F+, Ann Dermatol Venereol (French) 119, 671<br />

(1991): Lee AY+, <strong>Drug</strong> Intell Clin Pharm 25, 604<br />

(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223<br />

(1988): McFadden N, Dermatologica 176, 106<br />

(1985): Kauppinen K+, Br J Dermatol 112, 575<br />

(1985): Verbov J, Dermatologica 171, 60 (with acetaminophen)<br />

(1983): Mohamed KN+, Int J Dermatol 22, 548<br />

Peripheral edema<br />

Pruritus<br />

Rash (sic)<br />

(1991): Lee AY+, <strong>Drug</strong> Intell Clin Pharm 25, 604 (passim)<br />

Stevens–Johnson syndrome<br />

(1995): Roujeau JC+, NEnglJMed333(24), 1600<br />

(1995): Wolkenstein P+, <strong>Drug</strong> Saf 13, 56<br />

Toxic epidermal necrolysis<br />

(1998): von Boxberg C+, Dtsch Med Wochenschr (German)<br />

123, 866 (fatal)<br />

(1996): Blum L+, JAmAcadDermatol34, 1088<br />

(1995): Roujeau JC+, NEnglJMed333(24), 1600<br />

(1993): Correia O+, Dermatology 186, 32<br />

(1992): Saiag P+, JAmAcadDermatol26, 567<br />

(1991): Rosenthal E+, Presse Med (French) 20, 1459<br />

(1987): Guillaume JC+, Arch Dermatol 123, 1166<br />

(1983): Tagami H+, Arch Dermatol 119, 910<br />

Urticaria<br />

Mucosal<br />

Xerostomia

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!